Validating CGM for GDM

Recruiting now · Not applicable

Conditions studied: Gestational Diabetes Mellitus (GDM)

In brief

This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.

Key facts

Study ID

NCT06858787

Run by

Icahn School of Medicine at Mount Sinai

People needed

150

Starts

2025-10-02

Expected to finish

2028-04-01

Last updated by the study team

2026-07-24

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Ages 18-50
• Singleton pregnancy between 24-32 weeks gestational age
• Prenatal care and delivery at Mount Sinai Hospital

You may not qualify if…

• Multiple fetal gestation
• Preexisting diabetes
• Concurrent use of steroids
• Anomalous fetus
• Insufficient prenatal care (identified as missing half the recommended visits or establishing care after 20 weeks gestation)
• Unable to tolerate oral glucose test

Where it is running

• Icahn School of Medicine at Mount Sinai — New York, New York, United States (enrolling)
• Mount Sinai South Nassau — Oceanside, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.